2022976-34-5 Usage
Uses
Used in Organic Synthesis:
(5-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl)boronic acid is used as a reagent in organic synthesis for the formation of carbon-carbon and carbon-heteroatom bonds. Its boronic acid functional group plays a crucial role in facilitating these bond formations, making it a versatile component in the synthesis of complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, (5-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl)boronic acid is used as a key intermediate in the development of new drugs. Its unique structure allows for the creation of molecules with potential therapeutic properties, contributing to the advancement of medicinal chemistry.
Used in Agrochemicals:
(5-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl)boronic acid also finds application in the agrochemical sector, where it is utilized in the synthesis of compounds with pesticidal or herbicidal properties. Its ability to form stable bonds with other molecules makes it a valuable asset in the development of effective and targeted agrochemicals.
Used in Materials Science:
In the field of materials science, (5-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-4-yl)boronic acid is employed in the synthesis of new materials with specific properties. Its involvement in the formation of carbon-heteroatom bonds can lead to the creation of materials with unique characteristics, such as enhanced stability or reactivity, which can be beneficial in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 2022976-34-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,0,2,2,9,7 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2022976-34:
(9*2)+(8*0)+(7*2)+(6*2)+(5*9)+(4*7)+(3*6)+(2*3)+(1*4)=145
145 % 10 = 5
So 2022976-34-5 is a valid CAS Registry Number.
2022976-34-5Relevant academic research and scientific papers
INHIBITORS OF KRAS G12C PROTEIN AND USES THEREOF
-
, (2021/12/28)
Provided are novel compounds useful as inhibitors of the KRAS protein, as well as pharmaceutical compositions comprising these compounds and methods of treatment by administration of these compounds or the pharmaceutical compositions.
Tetrahydroquinazoline Derivatives Useful as Anticancer Agents
-
, (2019/08/26)
Compounds of the general formula: processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.
